Dr. Jacques Corbeil focuses on using the latest techniques in bioinformatics and machine learning to assist and facilitate the processes of diagnosis and prognosis determination and to optimize response to treatment. Modern genomic techniques generate a deluge of data that needs to be interpreted using novel bioinformatic approaches. Dr. Corbeil uses state-of-the-art instrumentation and big data analytics to facilitate the interpretation of complex phenotypic data. His research includes investigating how infectious microorganisms interact with their hosts, examining the effects of antibiotics on our microbial flora, exploring how to design small molecules and drugs to interfere with specific microbial functions and integrating omic data in cancer research. Dr. Corbeil operates at the interface of computer and omic sciences.
Dr. Corbeil completed his undergraduate work at Laval University. He obtained his Ph.D. from the University of New South Wales, Sydney, Australia, and received postdoctoral training at the University of California San Diego; continuing on as a faculty member and rising to the rank of Associate Professor until his return to Canada as holder of the Tier 1 Canada Research Chair in Medical Genomics.
2705, boulevard Laurier
R-0709
Québec, Québec
Canada G1V 4G2
Latest news
- Bachelot, GuillaumePostdoctoral fellowCHUL+1 418-525-4444guillaume.bachelot@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2 - Brière, FrancisDoctoral studentCHUL+1 418-525-4444, extension 46333francis.briere.1@ulaval.cafrancis.briere@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-5711
Québec, QC
Canada G1V 4G2 - Dominguez, Juan ManuelDoctoral studentCHUL+1 418-525-4444, extension 46337juan-manuel.dominguez@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-5711
Québec, QC
Canada G1V 4G2 - Francovic-Fontaine, ÉlinaDoctoral studentCHUL+1 418-525-4444, extension 46333elina.francovic-fontaine.1@ulaval.caelina.francovic-fontaine@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-5711
Québec, QC
Canada G1V 4G2 - Godon, ThibaudDoctoral studentCHUL+1 418-525-4444, extension 42296thibaud.godon@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-5711
Québec, QC
Canada G1V 4G2 - Kpanou, Sewagnouin RogiaDoctoral studentsewagnouin-rogia.kpanou.1@ulaval.ca
- Lavertu, AnthonyEmployeeCHUL+1 418-525-4444, extension 42296anthony.lavertu@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-5711
Québec, QC
Canada G1V 4G2 - Maheux, MaximDoctoral studentCHUL+1 418-525-4444, extension 46333maxim.maheux@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-5711
Québec, QC
Canada G1V 4G2 - Paré, ÉmanuelDoctoral studentemanuel.pare@crchudequebec.ulaval.ca
- Pic, ÉmilieEmployeeCHUL+1 418-525-4444, extension 49311emilie.pic@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-2765
Québec, Québec
Canada G1V 4G2 - Sahnoun, YasmineMaster studentCHUL+1 418-525-4444, extension 47959
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Velimirovic, MinjaDoctoral studentCHUL+1 418-525-4444, extension 46333minja.velimirovic.1@ulaval.caminja.velimirovic@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-5711
Québec, QC
Canada G1V 4G2
Learning self-supervised molecular representations for drug-drug interaction prediction
Journal ArticleBMC Bioinformatics, 25 (1), 2024.
Substitution of dietary monounsaturated fatty acids from olive oil for saturated fatty acids from lard increases low-density lipoprotein apolipoprotein B-100 fractional catabolic rate in subjects with dyslipidemia associated with insulin resistance: a randomized controlled trial
Journal ArticleAm J Clin Nutr, 119 (5), 2024.
Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study
Journal ArticleClin Infect Dis, 78 (3), 2024.
Phylogenomic insights into evolutionary trajectories of multidrug resistant S. pneumoniae CC271 over a period of 14 years in China
Journal ArticleGenome Med, 15 (1), 2023.
Characterization of vancomycin-resistance vanD gene clusters in the human intestinal microbiota by metagenomics and culture-enriched metagenomics
Journal ArticleJAC Antimicrob Resist, 5 (2), 2023.
Large-scale analysis of circulating glutamate and adipose gene expression in relation to abdominal obesity
Journal ArticleAmino Acids, 54 (9), 2022.
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
Journal ArticleMetabolites, 12 (5), 2022.
Flexible protein database based on amino acid k-mers
Journal ArticleSci Rep, 12 (1), 2022.
The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers
Journal ArticleInfluenza Other Respir Viruses, 16 (5), 2022.
Single-cell transcriptomics of the ventral posterolateral nucleus-enriched thalamic regions from HSV-1-infected mice reveal a novel microglia/microglia-like transcriptional response
Journal ArticleJ Neuroinflammation, 19 (1), 2022.
Active projects
- Antimicrobial resistance genes in bioaerosols in Canadian arctic, rural, and urban environments: sources, profiles, transport and fate, from 2019-12-01 to 2025-11-30
- Chaire de recherche du Canada en Medical genomics, from 2018-01-01 to 2024-12-31
- Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy, from 2016-07-01 to 2025-03-31
- Development of an advanced multiplexed lab-on-a-chip system for highthroughput screening using organ-on-a-chip technology to support Al drug discovery, from 2024-03-01 to 2025-02-28
- Ecogenomics of mining areas for sustainable Canadian North (GENOSCAN), from 2020-11-01 to 2024-12-31
- Extreme zooming on intestinal permeability and the western-style diet: Unravelling the role of dietary antigens on the prevalence of cardiometabolic and mental health diseases in the North, from 2020-11-01 to 2024-12-31
- Identification of innate immune pathways as targets for immunomodulatory therapy in herpes simplex virus encephalitis, from 2023-10-01 to 2028-09-30
- L'empreinte métabolomique plasmatique des produits laitiers: un reflet de leur consommation et une fenêtre sur leurs effets cardiométaboliques, from 2023-01-01 to 2025-10-01
- Observatoire international sur les impacts sociétaux de l'intelligence artificielle et du numérique, from 2018-04-01 to 2025-03-31
- PandemicStop-AI: for an accelerated response to pandemics, from 2024-03-01 to 2028-03-31
- PandemicStop-AI: for an accelerated response to pandemics, from 2024-03-01 to 2028-03-31
- Unravelling the impact of diet on cardiovascular health in heterozygous familial hypercholesterolemia: a metabolomic approach, from 2021-10-01 to 2025-09-30
- Validation de la mesure d’expression génique unicellulaire à partir d’un échantillon de tissu hépatique chez des sujets avec une suspicion clinique de stéatose hépatique non-alcoolique., from 2022-08-24 to 2025-03-31
Recently finished projects
- Acides biliaires et maladies inflammatoires chroniques de l’intestin : et si la solution était dans l’assiette?, from 2022-03-03 to 2023-03-02
- Déterminer la qualité de la polypharmacie chez les aînés : une approche basée sur l’intelligence artificielle, from 2020-04-01 to 2023-03-31
- Développement d'une technologie de contrôle de la qualité des plantes en cours du procédé manufacturier de médicaments en utilisant la spectrométrie de masse à haut débit couplée à des approches en apprentissage automatique , from 2020-03-19 to 2023-03-31
- Développement d’algorithmes d’IA pour soutenir le développement de médicaments oncologiques, from 2024-04-01 to 2024-08-31
- Dissecting host-microbiome modifiers of type 2 diabetes risk - Objective 1.3, from 2019-11-01 to 2024-10-31
- Exploration multi-omique des biopsies liquides pour dépister les porteurs de bactéries pathogènes et leurs résistances, from 2023-04-24 to 2024-04-23
- Prédire l'évolution de l'hépatite C par la fédération de données et l'intelligence artificielle : enjeux éthiques, juridiques, sociaux et de vie privée, from 2019-04-01 to 2024-03-31
- Rôle des habitudes de vie sur le microbiote et la réponse clinique à l’immunothérapie en cancer de la vessie, from 2023-04-20 to 2024-03-31
- UVILUQ: l'utilisation des biopsie liquides pour le monitoring de l'état de santé des écosystèmes marins côtiers, from 2020-07-01 to 2023-06-30
- Validation des marqueurs cellulaires ChromaLive sur modèles d'organopuces, from 2022-12-12 to 2023-08-23